[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632025":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":38,"collaborators":7,"id":40,"slug":7,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Marta Tagliabue, MD","Istituto Europeo di Oncologia","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","00390257489405","marta.tagliabue@ieo.it",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"francesca lombardi","00390257489425","francesca.lombardi@ieo.it",[23],{"facility":5,"status":24,"city":25,"state":26,"zip":27,"country":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Milan","MI","20141","Italy",{"type":30,"coordinates":31},"Point",[32,33],9.18951,45.46427,{"lat":33,"lon":32},[36],{"name":10,"role":15,"phone":37,"phoneExt":7,"email":17},"00390257489495",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100632025",false,"NCT07508319","Role of the Immune System in Preventing Laryngeal Cancer","Laryngeal Dysplasia and Progression to Carcinoma: Investigating Genetic and Immune Alterations Predictive of Malignant Transformation","Inclusion Criteria:\n\n* Histopathological diagnosis of laryngeal dysplasia.\n* Age \\>18 years and informed consent.\n\nExclusion Criteria:\n\n* Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.\n* Congenital or acquired immunodeficiency disorders.\n* Synchronous malignancies.\n* Immunosuppressive therapy.\n* Age \\\u003C18 years or absence of research consent.","ALL","18 Years","99 Years",{"count":50,"type":51},3,"ESTIMATED","OBSERVATIONAL","Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation",[55],"Head & Neck Cancer",[57],"Laryngeal dysplasia","2026-03-31",{"date":60,"type":61},"2026-04-02","ACTUAL",{"date":63,"type":61},"2025-11-19",{"date":65,"type":51},"2026-12-31",{"name":5,"class":6},1]